Becton, Dickinson and Co.
BDX
Key stats
- Open
- 215.68
- Day high
- 216.85
- Day low
- 213.34
- Previous close
- 214.52
- Volume
- 1.76M
- VWAP
- 215.35
- 52-week high
- 216.85
- 52-week low
- 140.11
- Market cap
- 58.43B
- Shares out
- 275.54M
- Employees
- 72,000
- Listed
- 1963
About Becton, Dickinson and Co.
Following the separation of the life science segment, Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · FRANKLIN LAKES, NJ · bd.com
Options · expiring Nov 20
Nov 12, 4:00 PM ET- Call open interest
- 1.7K
- Put open interest
- 1.9K
- Put/call
- 1.09
- At-the-money IV
- 24.2%
| Contract | Last | Traded | Volume | Open int. | IV |
|---|---|---|---|---|---|
| 200 put | 0.20 | Nov 12, 2:09 PM | 103 | 10 | 33.7% |
| 210 call | 5.35 | Nov 11, 10:30 AM | 8 | 358 | 20.1% |
| 180 put | 0.05 | Nov 11, 3:33 PM | 8 | 69 | 61.7% |
| 240 call | 0.20 | Nov 9, 12:59 PM | 7 | 48 | 39.0% |
| 200 call | 13.68 | Nov 11, 2:48 PM | 6 | 109 | — |
| 175 put | 0.33 | Nov 12, 9:40 AM | 5 | 81 | 79.8% |
Quarterly results
Massive · Aug 6, 2026| Q3 2026 to Jun 30, 2026 | Q2 2026 to Mar 31, 2026 | Q1 2026 to Dec 31, 2025 | Q4 2025 to Sep 30, 2025 | |
|---|---|---|---|---|
| Revenue | $4.98B | $4.71B | $5.25B | $5.89B |
| Gross profit | $2.31B | $2.15B | $2.41B | $2.80B |
| Operating income | $663.00M | $93.00M | $601.00M | $981.00M |
| Net income | $377.00M | −$311.00M | $382.00M | $493.00M |
| Diluted EPS | 1.37 | -1.11 | 1.34 | 1.71 |
| Operating cash flow | $577.00M | $673.00M | $656.00M | $1.35B |
| Assets | $50.73B | $50.83B | $54.84B | $55.33B |
| Liabilities | $26.32B | $26.70B | $29.56B | $29.93B |
| Equity | $24.42B | $24.13B | $25.28B | $25.39B |
Technicals
Massive · Nov 12, 2026- 50-day average190.32
- 200-day average169.95
- RSI (14 days)73.8
Short interest
Massive · Oct 30, 2026- Oct 30, 20268.11M shares · 5.2 days to cover
- Oct 15, 20268.91M shares · 5.5 days to cover
- Sep 30, 20269.78M shares · 4.9 days to cover
- Sep 15, 202611.32M shares · 7.2 days to cover
Dividends
Massive · Dec 10, 2026- Ex Dec 10, 2026, paid Dec 31, 20261.0600 · 4 a year
- Ex Sep 9, 2026, paid Sep 30, 20261.0500 · 4 a year
- Ex Jun 9, 2026, paid Jun 30, 20261.0500 · 4 a year
- Ex Mar 10, 2026, paid Mar 31, 20261.0500 · 4 a year
- Ex Dec 8, 2025, paid Dec 31, 20251.0500 · 4 a year
- Ex Sep 8, 2025, paid Sep 30, 20251.0400 · 4 a year
- Ex Jun 9, 2025, paid Jun 30, 20251.0400 · 4 a year
- Ex Mar 10, 2025, paid Mar 31, 20251.0400 · 4 a year
Related companies
MassiveNews coverage
No stories about Becton, Dickinson and Co. right now.